Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400

被引：181

作者：

Herbst, Roy S. ^{[1
]}

Gandara, David R. ^{[2
]}

Hirsch, Fred R. ^{[3
]}

Redman, Mary W. ^{[4
,5
]}

LeBlanc, Michael ^{[4
,5
]}

Mack, Philip C. ^{[2
]}

Schwartz, Lawrence H. ^{[6
]}

Vokes, Everett ^{[7
]}

Ramalingam, Suresh S. ^{[8
]}

Bradley, Jeffrey D. ^{[9
]}

Sparks, Dana ^{[10
]}

Zhou, Yang ^{[1
]}

Miwa, Crystal ^{[10
]}

Miller, Vincent A. ^{[11
]}

Yelensky, Roman ^{[11
]}

Li, Yali ^{[11
]}

Allen, Jeff D. ^{[12
]}

Sigal, Ellen V. ^{[12
]}

Wholley, David ^{[13
]}

Sigman, Caroline C. ^{[14
]}

Blumenthal, Gideon M. ^{[15
]}

Malik, Shakun ^{[16
]}

Kelloff, Gary J. ^{[17
]}

Abrams, Jeffrey S. ^{[18
]}

Blanke, Charles D. ^{[19
,20
]}

Papadimitrakopoulou, Vassiliki A. ^{[21
]}

机构：

[1] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06520 USA

[2] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA

[3] Univ Colorado, Dept Med Oncol, Hlth Sci Ctr, Aurora, CO USA

[4] SWOG Stat Ctr, Seattle, WA USA

[5] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA

[6] Columbia Univ, Dept Radiol, Coll Med, New York, NY USA

[7] Univ Chicago Med & Biol Sci, Dept Med, Chicago, IL USA

[8] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA

[9] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO USA

[10] SWOG Operat Off, San Antonio, TX USA

[11] Fdn Med, Cambridge, MA USA

[12] Friends Canc Res, Washington, DC USA

[13] Fdn Natl Inst Hlth, Bethesda, MD USA

[14] CCS Associates, Mountain View, CA USA

[15] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA

[16] NCI, Ctr Canc Res, Bethesda, MD 20892 USA

[17] NCI, Canc Imaging Program, Bethesda, MD 20892 USA

[18] NCI, Canc Therapy Evaluat Program, Bethesda, MD 20892 USA

[19] SWOG Grp Chairs Office, Portland, OR USA

[20] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA

[21] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

CLINICAL CANCER RESEARCH | 2015年 / 21卷 / 07期

基金：

美国国家卫生研究院;

关键词：

SELECTIVE INHIBITOR; CLINICAL-TRIALS; ONCOLOGY; PALBOCICLIB; ALECTINIB; GENOMICS; AZD4547; TARGETS; POTENT; BAR;

D O I：

10.1158/1078-0432.CCR-13-3473

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The Lung Master Protocol (Lung-MAP, S1400) is a ground-breaking clinical trial designed to advance the efficient development of targeted therapies for squamous cell carcinoma (SCC) of the lung. There are no approved targeted therapies specific to advanced lung SCC, although The Cancer Genome Atlas project and similar studies have detected a significant number of somatic gene mutations/amplifications in lung SCC, some of which are targetable by investigational agents. However, the frequency of these changes is low (5%-20%), making recruitment and study conduct challenging in the traditional clinical trial setting. Here, we describe our approach to development of a biomarker-driven phase II/II multisubstudy "Master Protocol," using a common platform(next-generation DNA sequencing) to identify actionable molecular abnormalities, followed by randomization to the relevant targeted therapy versus standard of care. (C) 2015 AACR.

引用

页码：1514 / 1524

页数：11

共 50 条

[1] Lung-MAP (SWOG S1400): A Biomarker-Driven Protocol Accelerating Development of Squamous Cell Lung Cancer Therapies
Herbst, Roy S.
ANNALS OF ONCOLOGY, 2015, 26 : 5 - 5
[2] Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol
Redman, Mary W.
Papadimitrakopoulou, Vassiliki A.
Minichiello, Katherine
Hirsch, Fred R.
Mack, Philip C.
Schwartz, Lawrence H.
Vokes, Everett
Ramalingam, Suresh
Leighl, Natasha
Bradley, Jeff
Miao, Jieling
Moon, James
Highleyman, Louise
Miwa, Crystal
LeBlanc, Michael L.
Malik, Shakun
Miller, Vincent A.
Sigal, Ellen, V
Adam, Stacey
Wholley, David
Sigman, Caroline
Smolich, Beverly
Blanke, Charles D.
Kelly, Karen
Gandara, David R.
Herbst, Roy S.
LANCET ONCOLOGY, 2020, 21 (12): : 1589 - 1601
[3] Lung Master Protocol in Squamous Cell Lung Cancer (Lung-MAP, S1400)
Gandara, David R.
Redman, Mary
Herbst, Roy
Abrams, Jeff
Malik, Shakun
Sigal, Ellen
Hirsch, Fred R.
Mack, Philip C.
Papadimitrakopoulou, Vassiliki
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S80 - S80
[4] Lung-MAP (SWOG S1400): Design, implementation, and lessons learned from a biomarker-driven master protocol (BDMP) for previously-treated squamous lung cancer (sqNSCLC).
Redman, Mary Weber
Papadimitrakopoulou, Vassiliki
Minichiello, Katherine
Gandara, David R.
Hirsch, Fred R.
Mack, Philip C.
Schwartz, Lawrence Howard
Vokes, Everett E.
Ramalingam, Suresh S.
Leighl, Natasha B.
Bradley, Jeffrey
LeBlanc, Michael Leo
Malik, Shakuntala
Miller, Vincent A.
Sigal, Ellen, V
Adam, Stacey
Blanke, Charles David
Kelly, Karen
Herbst, Roy S.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[5] Lung Master Protocol (Lung-MAP) Next Generation Sequencing Analysis of Advanced Squamous Cell Cancers (SWOG S1400)
Kozono, D.
Hua, X.
Wu, M.
Tolba, K.
Waqar, S.
Dragnev, K.
Cheng, H.
Hirsch, F.
Mack, P.
Kelly, K.
Herbst, R.
Gandara, D.
Redman, M.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S176 - S177
[6] Lung-MAP (S1400) Lung Master Protocol: Accrual and Genomic Screening Updates
Papadimitrakopoulou, Vassiliki
Redman, Mary
Gandara, David R.
Hirsch, Fred R.
Mack, Philipp
Borghaei, Hossein
Langer, Corey
Wade, James
Edelman, Martin
Albain, Kathy
Lara, Primo
Aggarwal, Charu
Socinski, Mark
Gettinger, Scott
Bazhenova, Lyudmila
Malik, Shakun
Miller, Vincent
Mcdonough, Shannon
Sigal, Ellen V.
Kelly, Karen
Herbst, Roy
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S439 - S440
[7] Lung-MAP Next-Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (SWOG S1400)
Kozono, David
Hua, Xing
Wu, Michael C.
Tolba, Khaled A.
Waqar, Saiama N.
Dragnev, Konstantin H.
Cheng, Haiying
Hirsch, Fred R.
Mack, Philip C.
Gray, Jhanelle E.
Kelly, Karen
Borghaei, Hossein
Herbst, Roy S.
Gandara, David R.
Redman, Mary W.
JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (12) : 1618 - 1629
[8] Representativeness of patients enrolled in the Lung Cancer Master Protocol (Lung-MAP).
Vaidya, Riha
Unger, Joseph M.
Qian, Lu
Minichiello, Katherine
Herbst, Roy S.
Gandara, David R.
Neal, Joel W.
Leal, Ticiana
Patel, Jyoti D.
Dragnev, Konstantin H.
Waqar, Saiama Naheed
Edelman, Martin Joseph
Sigal, Ellen V.
Adam, Stacey
Malik, Shakun M.
Blanke, Charles David
LeBlanc, Michael Leo
Kelly, Karen
Redman, Mary Weber
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[9] Progress in Lung Squamous Cell Carcinoma from the Lung-MAP Master Protocol (S1400) Sub-Studies S1400A, S1400B, S1400C and S1400D
Herbst, R.
Redman, M.
Gandara, D. R.
Hirsch, F. R.
Mack, P.
Borghaei, H.
Langer, C.
Wade, J.
Engelman, J.
Edelman, M.
Albain, K.
Lara, P.
Aggarwal, C.
Socinski, M.
Gettinger, S.
Bazhenova, L.
Waqar, S.
Robert, F.
Kiefer, G.
Bradley, J.
Crawford, J.
Mcgary, E.
Rafique, N.
Petro, D.
Hoffman, P.
Zhou, Y.
Miao, J.
Griffin, K.
Mcdonough, S.
Miwa, C.
Malik, S.
Miller, V.
Sigal, E.
Adam, S.
Blanke, C.
Kelly, K.
Papadimitrakopoulou, V.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1783 - S1784
[10] Representativeness of Patients Enrolled in the Lung Cancer Master Protocol (Lung-MAP)
Vaidya, Riha
Unger, Joseph M.
Qian, Lu
Minichiello, Katherine
Herbst, Roy S.
Gandara, David R.
Neal, Joel W.
Leal, Ticiana A.
Patel, Jyoti D.
Dragnev, Konstantin H.
Waqar, Saiama N.
Edelman, Martin J.
Sigal, Ellen V.
Adam, Stacey J.
Malik, Shakun
Blanke, Charles D.
Leblanc, Michael L.
Kelly, Karen
Gray, Jhanelle E.
Redman, Mary W.
JCO PRECISION ONCOLOGY, 2023, 7

← 1 2 3 4 5 →